Financings
Moss Genomics closes $100,000 private placement
MOSS · Price
Executive Summary
- Moss Genomics Inc. closed a non-brokered private placement of 555,555 common shares for $100,000 in gross proceeds, with net proceeds designated for general working capital.
- The company issued 5,164,213 common shares as consideration for asset purchase agreements executed between May and July 2025, resulting in the acquisition of approximately 224.75 ETH.
- Following these transactions, the total issued and outstanding share count stands at 63,414,545, and the company has scheduled its annual and special general meeting for November 13, 2025.
Key Details
- Private Placement Details:
- Structure: Non-brokered private placement.
- Closing Date: November 11, 2025.
- Shares Issued: 555,555 common shares.
- Price Per Share: $0.18 CAD.
- Gross Proceeds: $100,000.
- Finders' Fees: None paid.
- Use of Proceeds: General working capital.
- Asset Purchase / Share Issuance Details:
- Shares Issued: 5,164,213 common shares.
- Deemed Price Per Share: $0.18 CAD.
- Aggregate Deemed Consideration: $966,435.
- Assets Acquired: Approximately 224.7523 Ethereum (ETH).
- Average Cost of ETH: $3,833 per ETH.
- Agreement Dates: Asset purchase agreements entered into between May 13, 2025, and July 14, 2025.
- Corporate Structure & Governance:
- Total Shares Outstanding: 63,414,545 common shares post-transaction.
- Hold Periods: All securities issued are subject to applicable statutory hold periods under Canadian securities laws.
- Meeting Schedule: Annual and special general meeting scheduled for November 13, 2025, to be conducted virtually.
- Reference: This announcement completes the private placement and share issuances first announced on February 3, 2025.